Celgene
REBLOZYL
Manufacturer:
Celgene
Name:
REBLOZYL
HCPCS Code Descriptor:
Injection, luspatercept-aamt, 0.25 mg
Category:
J Code
HCPCS:
J0896
NDC(s):
59572-0711-01, 59572-0775-01
Primary Type:
Anti-Anemia
Generic/Specialty Status:
Single-Source
Route of Administration:
Subcutaneous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
REBLOZYL is an Anti-Anemia drug manufactured by Celgene and administered via the Subcutaneous route of administration. The J Code: J0896 is aligned to the drug REBLOZYL.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/20
HCPCS Effective Date:
7/1/20
HCPCS Short Description:
Inj luspatercept-aamt 0.25mg
Billing and Coding Guide:
https://www.bmsaccesssupport.bmscustomerconnect.com/servlet/servlet.FileDownload?file=00P4z00001S42ZrEAJ
Patient Assistance:
https://www.bmsaccesssupport.bmscustomerconnect.com/patient